These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 28276823)

  • 1. The role of MALAT-1 in the invasion and metastasis of gastric cancer.
    Chen D; Liu L; Wang K; Yu H; Wang Y; Liu J; Guo Y; Zhang H
    Scand J Gastroenterol; 2017; 52(6-7):790-796. PubMed ID: 28276823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of long non-coding RNA XLOC_010235 regulates epithelial-to-mesenchymal transition to promote metastasis by associating with Snail1 in gastric cancer.
    Liu YY; Chen ZH; Peng JJ; Wu JL; Yuan YJ; Zhai ET; Cai SR; He YL; Song W
    Sci Rep; 2017 May; 7(1):2461. PubMed ID: 28550287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins.
    Fang Z; Zhang S; Wang Y; Shen S; Wang F; Hao Y; Li Y; Zhang B; Zhou Y; Yang H
    BMC Cancer; 2016 Sep; 16(1):706. PubMed ID: 27586393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
    Dong Y; Wang ZG; Chi TS
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen‑like‑protein 1 promotes the invasion and metastasis of gastric cancer and is associated with poor prognosis.
    Zhang Y; Qiao HX; Zhou YT; Hong L; Chen JH
    Mol Med Rep; 2018 Aug; 18(2):1465-1472. PubMed ID: 29845203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
    Yan K; Tian J; Shi W; Xia H; Zhu Y
    Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition.
    Ying L; Chen Q; Wang Y; Zhou Z; Huang Y; Qiu F
    Mol Biosyst; 2012 Sep; 8(9):2289-94. PubMed ID: 22722759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
    Wu J; Weng Y; He F; Liang D; Cai L
    Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA CHRF promotes cell invasion and migration via EMT in gastric cancer.
    Gong J; Wang Y; Shu C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1168-1176. PubMed ID: 32096147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.
    Chen Z; Wu J; Huang W; Peng J; Ye J; Yang L; Yuan Y; Chen C; Zhang C; Cai S; He Y; Wu S; Song W
    Cell Physiol Biochem; 2018; 47(6):2432-2444. PubMed ID: 29991048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition.
    Xie R; Wang X; Qi G; Wu Z; Wei R; Li P; Zhang D
    Tumour Biol; 2016 Sep; 37(9):12049-12059. PubMed ID: 27179963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigation.
    Zhao Y; Guo Q; Chen J; Hu J; Wang S; Sun Y
    Oncol Rep; 2014 Jan; 31(1):358-64. PubMed ID: 24247585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA N-BLR Upregulates the Migration and Invasion of Gastric Adenocarcinoma.
    Youn YH; Byun HJ; Yoon JH; Park CH; Lee SK
    Gut Liver; 2019 Apr; 13(4):421-429. PubMed ID: 30970439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
    J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway.
    Hu J; Wang M; Yang Y; Xing Y; Li S
    Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.